论文部分内容阅读
ＢＭＳ的Ｄ－ｓｏｔａｌｏｌ停止使用Ｂｒｉｓｔｏｌ－ＭｙｅｒＳｑｕｉｂｂ（ＢＭＳ）正在研究的口服抗心律失常药Ｄ－索他洛尔（Ｄ－ｓｏｔａｌｏｌ）的死亡率试验（ＳＷＯＲＤ）已被迫中止，因为给药组的死亡率高于对照组。材料与安全监督委员会（ｔｈｅｄａｔａａｎｄ...
D-sotalol Stop for BMS The death rate trial (D-sotalol) of the oral antiarrhythmic drug D-sotalol being studied using Bristol-Myer Squibb (BMS) has been discontinued because of the death of the dosing group The rate was higher than the control group. Material and Safety Oversight Committee (thedataand ...